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ABSTRACT 
Preformulation is a study which deals which provides the framework for drug’s combination with pharmaceutical 
ingredients in the fabrication of dosage form. Preformulation study is to develop the elegant dosage form by the 
establishing kinetic rate profile, compatibility with the other ingredients, establish physicochemical parameter and 
polymorphism of the new drug. Among these properties the preformulation also provide the information regarding 
degradation process, adverse condition relevant to the drug, bioavailability, pharmacokinetics, toxicity, drug stability, 
partition coefficient, dissolution rate, and polymorphic forms. Preformulation studies strengthen the scientific 
foundation of the guidance, provide regulatory relief and conserve resources in the drug development and evaluation 
process, improve public safety standards, enhance product quality, facilitate the implementation of new technologies. 
According to ICH, all technical requirements for the application of drug approval were homonized in CTD format 
which are scientifically more elaborate by USFDA in QoS-QbR format. QbR is based on the principle of Quality by 
Design (QbD) which increased efficiently in the FDA review process. 
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INTRODUCTION 
Preformulation studies was established in 1950 & early 
1960. Almost all drugs are marketed as tablets, capsule 
or both. Prior to this development of major dosage form 
it is essential to investigate the physical & chemical 
properties of the drug substance alone or combined with 
excipients are formulated in the suitable form that can be 
administered
1.
 Preformulation commences this all drugs 
shows sufficient pharmacologic promise in animal’s 
models to warrant evaluation in man. These studies 
reflect on those physiochemical parameters of the new 
compound that would affect drug performance and 
development of efficacious dosage form
2.
 
The first learning phase of the drug is known as 
preformulation. Preformulation is the interference of the 
new drug entity and formulation development. 
Preformulation involve the application of 
biopharmaceutical principles of the physicochemical 
property of the drug with the goal of designing effective 
drug delivery system. Preformulation studies are an 
important tool for early development in the both of API 
and drug products. The interaction of the drug 
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component and excipients are used in the preformulation 
study. After the biological screening of the drug a formal 
preformulation should be started when a decision is 
made for further development of the compound in 
clinical trials. IND, NDA and ANDA guidelines issued 
by the US FDA and ICH recommended the 
preformulation studies. Preformulation investigation 
were designed to deliver all necessary data (especially 
physico-chemical, physico-mechanical and 
biopharmaceutical properties of the drug  substances, 
excipients and packaging materials) which influenced 
the formulation design, method of manufacturing, 
pharmacokinetic/biopharmaceutical  properties of the 
resulting product
3.
 Sustained release, sustained action, 
controlled release, extended action, timed release, depot 
and repository dosage forms are the terms used for that 
drug which is designed to achieve a prolonged 
therapeutic effect by the continuously releasing 
medication over an extended period of the time after the 
administration of single dose. The term “sustained 
release” has been constantly used to describe that 
pharmaceutical dosage form formulated to retard the 
release of a therapeutic agent
 4.
 Preformulation study of 
the zidovudine derivatives were carried out by using 
Differential Scanning Calorimetry, Thermogravimetry, 
X-Ray Powder Diffractometry and Aqueous Stability 
studies. X-Ray Powder diffractometry data demonstrated 
that compound which has 2-4 crystalline and 5-6 were 
amorphous. Preformulation and stability of the 
biological fluid of retrocycline RC-101 is a potentially 
anti-HIV topical microbicide. RC-101 was stable at pH 
3, 4 and 7 at 25
o
C and 37
o
C
3.
  
NEED/IMPORTANCE OF DOSAGE FORM1 
 To provide safe, effective & convenient delivery of 
accurate drug. 
 To protect from destructive environment such as 
oxygen or humidity. 
 To protect from the gastric acid and effect after oral 
administration. Example: enteric coated tablet. 
 To suppress the odor and taste of the drug. 
 To provide solubility and stability for that liquid 
preparation which are unstable or insoluble. 
Example: suspension. 
 To provide rate controlled drug action. Example: 
sustained release and controlled release tablet such as 
aspirin. 
OBJECTIVE OF PREFORMULATION 1 
 To formulate or develop the elegant dosage forms. 
 It provides knowledgeable information for the 
formulator to design an optimum drug delivery 
system. 
 It is the first step before formulating or development 
of raw material into dosage form. 
INVESTIGATION & RESEARCH ON THE 
PREFORMULATION 
A. Bulk characterization 
 Crystalllinity and polymorphism 
 Hygroscopicity 
 Fine particle characterization 
 Powder flow properties 
 Bulk density 
B. Solubility parameter 
 Ionization constant- pKa 
 pH solubility profile 
 Common ion effect-Ksp 
 Thermal effect 
 Solubilization 
 Partition coefficient  
 Dissolution 
C. Stability parameter 
 Stability in toxicology preparation 
 Solution stability 
 pH stability 
 Bulk stability 
 Compatibility 
BULK CHARACTERIZATION 
Bulk characterization deals with the almost all solid for 
of drug. Bulk properties of the solid form, such as 
particle size, bulk density and surface morphology, flow 
ability and strength and strength of agglomeration can 
significantly impact downstream formulation process. 
Therefore, comprehensive characterization of all 
preformulation bulk lots of is necessary to avoid 
misleading prediction of stability or solubility 
5.
 
1) Crystallinity and Polymorphism 
Crystallinity refers to the degree of structural order in a 
solid. Crystal habit and the internal structure of the drug 
can affect bulk and physicochemical properties. Habit is 
a description of outer appearance of crystal and the 
internal structure describe the molecular arrangement 
within the solid, changes in the internal structure usually 
after the crystal habit. Several examples of different 
habits of crystals are shown
. 2
 
 
Figure 1:  Differential habits of crystals 
1
 
Polymorphism is the ability of a compound to crystalline 
as more than one distinct crystalline species with 
different internal Latin. Many physiochemical properties 
vary with internal structure of solids e.g. melting point, 
density, hardness, crystal shape, optical property, 
solubility 
6
. Polymorphisms are of two types: 
Enantiotropic: enantiotropic polymorphisms can be 
reversely changed into another by varying temperature 
and pressure. E.g. sulphur, carbon, nitrogen and oxygen 
Monotropic polymorphism: polymorph is unstable at 
all temperature and pressure. E.g. glyceryl stearate.
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ANALYTICAL TECHNIQUE USED FOR CHARACTERIZATION OF SOLID: 
Method                                                          Material required per sample 
 Microscopy                                                          1mg 
 Fusion method                                                     1mg 
 Differential scanning Calorimetry (DSC)           2-5mg 
 Infrared spectroscopy                                          2-20mg 
 X-ray powder diffraction                                   500mg 
 Scanning electron microscopy                          2mg 
 Thermo gravimetric analysis                            10mg 
 
 
a) Microscopy: 
Almost all substances that are transparent when 
examined under a microscope that has crossed polarizing 
filters are either isotropic or anisotropic. Amorphous 
solid and non-crystalline solid organic compound are 
isotropic materials, which have single refractive index. 
When the plain polarized filter passed these isotropic 
substances do not transmit light and appear black. 
Materials more than one refractive index is anisotropic 
and appears bright against the black polarized 
background. The interference of colors is depending 
upon the crystal thickness and their refractive indices. 
Anisotropic are either uniaxial or biaxial. To obtain or 
describe the complete crystal form a crystallographic 
axes are required. The polarizing microscope fitted with 
a hot stage is a useful instrument for investigating 
polymorphism, melting points, transition temperature 
and rates of transition at controlled heating rate
. 2
 For 
describing the characterization of crystallinty of the drug 
the microscopy is divided into two types are: 
 Scanning Electron Microscopy (SEM) 
 Transmission Electron microscopy (TEM) 
SEM: SEM is used to visualize the surface of the drug 
molecule. In this microscopy the electron beam is passed 
from the electron gun which rapidly moves over the 
surface of the specimen which led to scan the surface of 
the drug. 
TEM: TEM is used to photograph detail structure within 
the drug molecule. A total magnification is about 20 
million times can be achieved and objects as small as 
2nm can be seen. TEM penetrate the surface of the drug 
and shows internal structure of the drug. 
 
a)                            b) 
Figure 2: a) Scanning electron microscopy     b) Transmission electron microscopy 
 
b) Fusion method (hot-melt method):  
In this fusion method, carrier is heated slightly above its 
melting point and the drug is incorporated into a matrix. 
Then the mixture is cooled with constant stirring. The 
dispersion may be cooled slowly to room temperature or 
rapidly in an ice bath 
7.
 The fusion method is also known 
as hot-melt method. This term can be used only when 
the starting material is crystalline in nature. When the 
dispersion is cooled the resultant product is pulverized 
and sieved. If the mixing of the components is 
performed by an extrusion process, then the method is 
known as the hot melt extrusion method 
8.
 
c) Differential Scanning Calorimetry (DSC/DTA): 
Differential Scanning Calorimetry (DSC) is one of the 
most widely used thermal analytical methods of 
analysis. The technique such as DSC (Differential 
Scanning Calorimetry) and DTA (differential Thermo 
Analysis) are based on the principal of measuring the 
changes in physical properties of a substance as a 
function of temperature when that substance is subjected 
to a controlled temperature program. DSC is defined as 
“A technique in which a difference in the heat flow 
(power) to the sample (pan) is monitored against time or 
temperature 
7.
 The plot is obtained from the DSC 
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instrument is seen as a heating rate versus temperature 
or time. Differential Scanning Calorimetry has evolved 
from the technique of Differential Thermal Analysis 
(DTA) but does not account for the fundamental change 
in the working principle 
6.
 It includes some changes in 
thermocouple sensor’s position and keeping the heat 
flux to the sample constant. DSC is also used to describe 
the physical and chemical property of the sample. DSC 
is classified into following types are: 
 Heat flux DSC 
 Power compensated DSC 8 
 
 
a)                                                                                                                              b) 
Fig.3: a) Machine view of DSC b) Schematic view 
C) Infrared Spectroscopy: 
Infrared spectroscopy is the spectroscopy that deals with 
the infrared region of the electromagnetic spectrum that 
is light with a longer wavelength and lower frequency 
than visible light. It is based on the absorption 
spectroscopy. The method or technique of infrared 
spectroscopy uses an instrument called infrared 
spectrometer to produce infrared spectrum 
9. 
 
 
     Fig.4: schematic view of IR Spectroscopy (Schematics of a two-beam absorption spectrometer. A beam of infrared light 
is produced, passed through an interferometer (not shown), and then split into two separate beams. One is passed 
through the sample, the other passed through a reference. The beams are both reflected back towards a detector, 
however first they pass through a splitter, which quickly alternates which of the two beams enters the detector. The two 
signals are then compared and a printout is obtained. This "two-beam" setup gives accurate spectra even if the intensity 
of the light source drifts over time.  
 
d) X-Ray Powder Diffraction (XRPD): 
XRPD was performed to observe the physical state of 
the solid dispersion and to evaluate any interaction 
between the drug carrier and adsorbent in solid 
dispersion. PAN analytical X-pert Pro V.1.6 with X-Pert 
Data Collector V2.1 software was used equipped with 
CuKα anode tube and difftactometer of radius 240mm. 
The XRD scan was performed using BB004 flat stage. 
The powdered sample was placed in a plastic sample 
holder of 1inch square. Data were collected at 45 KV 
and 40mA. Samples were scanned from 0-40.20 at a 
stop size of 0.0084 and scan rate of 1.00
 0
/min
. 10. 
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Fig.5: X-Ray diffraction technique 
 
e) Scanning Electron Microscopy (SEM): 
SEM is used to visualize the surface of the drug 
molecule. In this microscopy the electron beam is 
passed from the electron gun which rapidly moves over 
the surface of the specimen. This causes the release of 
shower of secondary electron and other type of variation 
which lead to see the scan the surface of the drug. The 
surface characteristics of the drug carrier, adsorbent and 
solid dispersion were suited using a scanning electron 
microscope equipped with JSM 6100. It provides the 
digital picture of the sample 
11
. Double sided adhesive 
tape was used to fix the sample onto a brass stub, which 
was coated in a sputter coater under vacuum. The SEM 
pictures for all samples were taken under a 
magnification of 10X 
12.
 
 
Fig.6: Scanning electron microscopy (Purdue 
University, West Lafayette, IN 47907, (765) 494-4600 
© 2014     Purdue University) 
f) Thermogravimetric Analysis: 
Thermo gravimetric analysis or thermal gravimetric 
analysis (TGA) is a method of thermal analysis in which 
changes in physical and chemical properties of material 
are measured 
2.
 As function of increasing temperature or 
as a function of physical phenomena, such as second 
order phase transitions including vaporization, 
sublimation, absorption, and adsorption and desorption. 
TGA also provide chemical phenomena including 
chemisorption, desolation, decomposition and solid-gas 
reaction. It is useful technique for the study of 
polymeric materials, including thermoplastic, thermo 
sets, composites, plastic films, fibers, coating and paints 
13.
 
 
Figure 7: Q50 TGA Instrument Scheme ( Kessler, 
Michael. "Lab 10: TGA" Laboratory Manual. Mat E 
453. Iowa State University. 13 November 2012) 
2) Hysgroscopicity 
A substance which absorbs sufficient moisture from the 
atmosphere is called hygroscopic. Many drug 
substances, particularly water-soluble salt forms have 
tendency to absorb atmospheric moisture 
14.
 Adsorption 
and equilibrium moisture content can depend upon the 
atmospheric humidity, temperature, surface area, 
exposure, and the mechanism or moisture uptake, as 
described by Van Campen. Some materials adsorb 
sufficient water to dissolve completely, as is observed 
with sodium chloride on a humid climate. Other 
hygroscopic substances adsorb water because of hydrate 
formation 
2.
 
To test for hygroscopicity bulk samples of drug are 
placed in open containers with a thin powder bed to 
assure maximum atmospheric exposure. These samples 
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are then exposed to a range of controlled relative 
humidity environments prepared with saturated aqueous 
salt solution. The moisture uptake by the sample can be 
monitored at the representative of handling (0 to 24 hrs0 
and storage (0 to 12 weeks) 
15.
  Analytic methods for 
monitoring the moisture level by Gravimetric Analysis, 
Thermo gravimetric analysis, Karl Fischer titration, or 
gas chromatography.    
3) Fine Particle Characterization 
 Bulk flow, formulation homogeneity and surface 
area controlled processes such as dissolution and 
chemical reactivity are directly affected by size, 
shape, and surface morphology of the drug particle. 
Before the preformulation each new drug should be 
tested with the smallest particle size as is practical 
facilitate preparation of homogeneous samples and 
maximize the drug’s surface area for interactions 11. 
 To determine the shape and size of the particle a 
light microscope with a calibrated grid usually 
provides adequate size and shape characterization for 
drug particles. Sampling and preparation of 
microscopic slide must be performed carefully to 
obtain representative dispersion 
16. 
The use of 
photomicrographs and a hemacytometer slide, as 
well as other sizing techniques may take this task 
slight less strenuous. In conjunction with light 
microscopy, stream containing devices such as 
Coulter counter and HIAC counter often provide a 
convenient method for characterizing the size 
distribution of a compound. Sample are prepared for 
analysis by the Coulter counter by dispersing the 
material in a conducting medium such as isotonic 
saline with the aid of ultrasound and a few drops of 
surfactant
12.
 A known volume of the suspension is 
then drowning into a tube through a small aperture 
across which a voltage is applied. As each particle 
passes through the hole counted the size acc. To the 
resistance generated by displacing that particle’s 
volume of conducting medium. 
 Sieve sample are used primarily for large samples of 
relatively large particles (~100 microns
) 17.
 
 Computer interfacing of image analysis techniques 
offers the greatest promise for the particle size 
analysis. 
 A more precise method for measurement of surface 
area is made by Brunauer Emmett and Teller (BET) 
by adsorption and desorption of nitrogen and 
calculating the value we can determine the surface 
area of particle. 
 Surface morphology may be observed by scanning 
electron microscopy (SEM) which serves to confirm 
qualitatively a physical observation related to surface 
area. Most modern SEM instruments also provide 
energy dispersive X-Ray spectroscopy analysis of 
surface metal ions, which may prove beneficial in 
deciphering an instability or incompatibility problem 
17.
 
 The laser diffraction has become preferred choice 
laser diffraction, alternative referred to as low angle 
laser light scattering (LALLS) can be used for the 
nondestructive analysis of wet or dry samples, with 
particle size range 0.02 to 2000 microns. Laser 
diffraction based particle size analysis relies on the 
fact that particles passing through a laser beam will 
scatter light at an angle that is directly related to their 
size. As particle size decreases the observed 
scattering angle increases logarithmically. E.g.The 
Master sizer 2000: a mastersizer has a fully 
optimized optical design which allows particles in 
the range of 0.02-2000 microns 
18.
 
 Instrument for laser diffraction: LA-960, S2-100, 
PSA300/ CAMSIZER, VIEWSIZER 3000. 
19
 
4) Powder Flow Characteristic  
Pharmaceutical powders may be broadly classified as 
free flowing or cohesive (non-free flowing). Most flow 
properties are significantly affected by changes in 
particle size, density, shape, electrostatic charge and 
adsorbed moisture which may arise from processing or 
formulation. 
Techniques: 
 FT4 Powder Rheometer: The FT4 Powder 
rheometer was originally designed to characterize the 
rheology or flow properties of powder. This remains 
a primary function today, but the instrument, 
accessories and methodologies have been 
continuously developed to the point where FT4 is 
now considered a universal tester 
20.
 
 1ml Shear Cell: The freeman technology 1ml hear 
cell allows very small powder samples to be 
automatically tested , minimizing the consumption of 
scare and valuable material. 
 Angle of Repose: Angle of repose has been used in 
the several branches of science to characterize the 
flow properties of solids. Angle of repose is a 
characteristic related to inter particulate friction or 
resistance to movement between particles. 
Experimental difficulties arise as a result of 
segregation of material and consolidation or aeration 
of the powder as the cone is formed. Despite its 
difficulties the method continues to be used in the 
pharmaceutical industry. The angle of repose is the 
three dimensional angle (relative to the horizontal 
base) assumed by a cone-like pile of material 
21.
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Table.1: For Angle of repose 
2
 
Flow Property Angle of Repose(degrees) 
Excellent  25-30 
Good 31-35 
Fair-aid not needed 36-40 
Passable-may hang up 41-45 
Poor-must agitate, vibrate 46-55 
Very poor 56-65 
Very,  very poor >66 
  
To calculate angle of repose following formula is used. 
                 
 Compressibility index and Hausner’s ratio: In 
recent years the compressibility index and the closely 
related Hausner’s ratio have become the simple, fast, 
and popular methods of predicting powder flow 
characteristics. The compressibility index has been 
proposed as an indirect measure of bulk density, size 
and shape, surface area, moisture content, and 
cohesiveness of materials influence the observed 
compressibility index 
18
. The compressibility index 
and the Hausner’s ratio are determined by measuring 
both the bulk volume and the tapped volume of 
powder. 
 The compressibility index and the Hausner’s ratio 
may be calculated using measured value for bulk 
density and tapped density as follows: 
Compressibility Index = 
                            
              
*100 
Hausner’s ratio = 
              
            
 
 
Table 2: Scale of flow ability 
Compressibility index (5%)  Flow character Hausner’s ratio 
≤10 Excellent 1.00-1.11 
11-15 Good 1.12-1.18 
16-20 Fair 1.19-1.25 
21-25 Passable 1.26-1.34 
26-31 Poor 1.35-1.45 
32-37 Very poor 1.46-1.59 
>38 Very, very poor >1.60 
 
 Flow through an orifice: The flow rate of material 
is depending on many factors, some of which are 
particle-related and some related to the process. 
Monitoring the rate of flow of material through an 
orifice has been proposed as a better measure of 
powder flow ability. Changes in flow rate as the 
container empties can also be observed. The flow 
rate through an orifice s generally measured as the 
mass per time flowing from any of a number of types 
of containers (cylinders, Funnel, hoppers). 
Measurement of the flow rate can be discrete 
increments or continuous 
22.
 
5)  Bulk Density  
Bulk density of a compound varies substantially with the 
method of crystallization, milling, or formulation.Once a 
density problem is identified, it is often easily corrected 
by milling, slugging, or formulation 
23.
 Bulk density is of 
great importance when one considers the size of high 
dose capsule product or the homogeneity of a low dose 
formulation in which there are large differences in drug 
and excipient densities. The bulk density of a powder is 
the ratio of the mass of an untapped powder sample and   
its volume. Including the contribution of the 
interparticulate void volume. Hence, the bulk density of 
powder particles and the spatial arrangement of particles 
in the powder bed 
2.
 
 
Figure 8:  The pKa determination for an organic amine 
drug candidate whose un-ionized form is exceedingly 
insoluble in water 
2 
 Measurement in graduated cylinder 
Apparent density is determined by pouring perceived 
(40- mesh) bulk drug into a graduated cylinder via a 
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large funnel and measuring the volume and weight “as 
is” 24. 
 Measurement in a volumeter 
The apparatus consist of top funnel fitted with a 1.0 mm 
containing four glass baffle plates over which the 
powder slides and bounces as it passes. At the bottom of 
the baffle box is a funnel that collects the powder and 
allows it to pour into a cup mounted directly below it. 
The cup they be cylindrical r cubical 
25. 
 Measurement in vessles  
The apparatus consist of a 100ml cylindrical vessel of 
stainless steel 52mm long and 54mm wide. 
Marketed drug: Amoxicillin trihydrate. 
Solubility analysis: 
Preformulation solubility studies focus on drug solvent 
system that could occur during the delivery candidate, 
for example a drug for oral administration should be 
examined for solubility in media having isotonic 
chloride ion concentration and acidic pH 
26.
 
Preformulation solubility studies usually includes 
determination of pka, temperature dependence, pH 
solubility profile, solubility products solubilization 
mechanisms and rate of dissolution analytical method 
that are particularly useful for solubility measurement 
including HPLC, UV, Spectroscopy, fluorescence 
spectroscopy and gas chromatography. For most drug 
reverse phase HPLC offer an efficient and accurate 
means of collecting solubility data. Solubility and 
dissolution experiment should have all factor defined, 
including pH, temp, ionic strength and buffer 
concentration 
2. 
Constant (PKA Determination) Ionization 
Determination of the dissociation constant for a drug 
capable of ionization within a pH range of the 1 to 10 is 
imp.Since solubility and consequently absorption can be 
altered by orders of magnitude with changing pH. The 
Henderson-hasselbalch equation provides an estimate of 
the ionized and un-ionized drug conc. at a particular pH 
27.
 
For acidic compound 
pH= pKa + log 
            
              
 
For basic compound 
pH= pKa + log
              
            
 
For a weekly acidic drug with pKa value greater than 3, 
the un-ionized form is present within the acidic content 
of the stomach, but the ionized drug is predominately in 
the neutral media of the intestine for basic drug such as 
erythro0mycin and papaverine, (pKa 8 to 9), the ionized 
form is predominant in both the stomach and intestine. A 
pKa values can be determined by a variety of analytic 
methods. Buffer, temp., ionic strength and cosolvent 
affect the pKa value 
28.
 
Method of determination of dissociation constant: 
a)  High Performace Liquid Chromatography 
(HPLC): 
HPLC is valuable technique for this separation of weak 
acids and bases . a general equation which relates the 
observed retention factor to the PH of the mobile phase 
the dissociation constants and the retention factors of the 
different ionic species has been used to determine 
dissociation constant of polyprotic  weak acid and base 
29. 
b) Hyper Rayleigh scattering: 
Hyper –Rayleigh   scattering (HRS) is second harmonic 
light scattering mediated by the molecular by the first 
hyperpolarizability and HRS is widely used to measure 
technique used to obtain the dissociation constant of 
weak organic acid in protic solvent 
30.
 The degree of 
dissociation of the acid can be varied by altering the 
initial conc. of the acid solution. HRS technique is based 
on a hoo-photon scattering process and powerful IR 
lasers.  
c) Calorimetry: 
All Calorimetry method work by the same principle a 
physical or chemical process takes place in a sample and 
amount of heat evolved is measured. For the 
measurement of pKa values, in isothermal titration 
Calorimetry (ITC) a regular acid-base titration is carried 
out inside the calorimeter while the energy required 
keeping the temp. constant is measured 
31.
 
d) U V Visible Spectroscopy: 
The principle of UV-visible spectroscopy is the 
absorption of electromagnetic radiation from the 200-
800 range and the following excitation to higher energy 
states 
32,3.
 UV-visible spectrophotometry handle 
compound with lower solubility and lower sample 
concentration. There are various UV methods such as 
simultaneous method, microliter plate method of multi 
wavelength spectroscopic method, second derivate 
method orthogonal method. 
e) Density Functional Theory (Dfi) Method: 
The density functional theory is the computerized 
method. DFI is nowadays one of the most popular 
methods for calculating pKa values. The pKa values 
where calculated with the jaguar pKa prediction modules 
using the thermodynamic cycle and following equation 
33.
 Where D is the free energy changed  
pKa = 1/ 2-3 RT* D 
f) Isohydric Solution Principle: 
This method is very sensitive method, useful for weak 
acid characterized by low pKa values. We can test the 
effect of contamination of weak acid or its salt by a 
strong acid or base or carbonate. The pKa determine by 
isohydric principle method by following equation. 
C = C+ C
2
. 10
PK1T 
g) Solvaton Method: 
In this method dissociation constant measure by 
calculating the Gibbs energy change for the 
deprotonating in the gas phase and then using the 
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salvation energies of the molecules ,anion and the proton 
to estimate the Gibbs free energy of salvation 
34.
 
h) Thermal Lensing Spectroscopy: 
Sung Ho Kim et al measure dissociation constant of 
thymol blue by using a portable Diode-laser/ fiber-optic 
thermal lensing spectroscopy , which consisted of a 
visible diode laser , a photodiode and an optical fiber 
35.
 
i) Flourimetric Method: 
Flourimetry is a relatively fast and accurate means of 
determining the dissociation constant of sparingly 
soluble aryl amines and hydroxyl aromatic compound 
36. 
j) Flourescence Polarization Method: 
Linda prystay determine equilibrium dissociation 
constant of peptides size range from a 7- mer at about 
1,400 Da (dermorphin) to a 22- mer at about 3,200 Da 
(3,2000) by using  fluorescence polarization saturation 
curve data 
37.
 
k) Mass Pectroscopy:  
The chromatography together with mass spectroscopy 
method allowed for the quick determination constant and 
mainly applicable for complex mixture 
38
. 
l) Surface Plasama Resonance: 
Surface plasma resonance (SPR) is generally accepted 
for the investigation of binding kinetics and binding 
strengths. SPR is most frequently used for studying 
bimolecular interaction. The principle of SPR 
measurement is relatively simple a “bait” ligand is 
immobilized on the gold surface of the gold surface of 
the SPR chip 
6,39
. 
 pH Solubility Profile 
The solubility of an acidic or basic drug depends on the 
pKa the ionizing functional group and  the un-ionized 
form. St , is equal to the following summation 
St = [BH+] + [B] 
Where BH+ is the protonated species and B is the free 
base. The PH at which both base and salt species are 
simultaneously is defined as the pH max or. 
St , pH = pH max = [BH+]s  + [B]s 
Where the subscript is denotes saturation. For weak 
bases in the pH region where the solubility of the 
protonated form is limiting, the molar solubility is  
St, pH- pH max = [BH+]s [B]s= [BH+] ( 1 + 
  
  
 ) 
Similarly, the solubility in the pH region where the free 
base is limiting is expressed as. 
PH max = pKa + LOG [B]s 
It therefore follows the pH max is defined as. 
pHmax = pKa + log 
    
      
 
At a solution pH equivalent to PH max, both the free 
base and salt with can exist simultaneously in 
equilibrium with a saturated solution. The PH max is 
verified by sampling precipitated drug from the 
equilibrated solution and confirming the presence of 
both drugs is the solubility-limiting species in solution, 
the concentration of the paired counter ion is usually the 
solubility determining factor 
40
. A particularly useful by 
Kramer and Flynn for organic hydrochlorides PH 
solubility profile dependence on solvent composition. 
While most of this discussion as focused on solubility 
product limitations of basic compound. The PH 
solubility profile for doxycycline (pKa 3.4) reported by 
Bogardus and backwoods illustrates a common ion 
effect for an amine hydrochlorides salt 
2. 
 
Figure 9: The pH solubility profile for doxycycline in aqueous hydrochloric acid at 25
o
C.At pH=2.16, both doxycycline 
monohydrate and doxycycline hydrochloride dehydrate were in equilibrium with solution. (From Lachman Leon, 
Lieberman Herbert A. and Kanig Joseph L. “The theory and pharmaceutical of industrial pharmacy” third edition, page 
no. 187) 
 
Common Ion Effect 
A common ion significantly reduces the solubility of a 
slightly soluble electrolyte. The common ion effect 
suppresser the ionization f a weak acid by adding f an 
ion that is a product of the equilibrium. The selling out 
result from the removal of water molecules as solvent 
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owing to the completing hydration of other ions. The 
reverse process salting in cries with larger anions.  E.g. 
benzoate, salivate which open the water structure. These 
hydro topics increase the solubility of properly water 
soluble compounds such as diazepam. 
Thermal Effect 
The heat of solution, represent the heat released or 
absorbed when a mole f solute s dissolved in large 
quantity of solvent, most commonly, the solution 
process is endothermic, or is profile is positive and thus 
increasing the solution temp. Increase the drug 
solubility. The working equation for determining Hs is: 
S= 
    
 
 
 
 
    
       Where , S is the molar solubility at temperature T and R  
is gas constant 
2,41.
 
The change in temperature produces changes in 
solubility. 
Solbilization 
For drug candidates with either poor water solubility or 
insufficient solubility for projected solution dosage 
forms preformulation studies should include limited 
experiments to identify possible mechanism for 
solubilization 
[2].
The solubility of poorly soluble 
nonelectrolytes can often be improved by orders of 
magnitude with suitable cosolvents such as ethanol, 
propylene, glycol, and glycerin. The extent of 
solubilization due to the chemical structure of the drug. 
That is the more nonpolar the solute, the greater is the 
solubilization achieved by cosolvent addition 
42.
 
NOVEL TECHNIQUES 
1) Hot-melt method (fusion method): 
The main advantage of this method is direct melting 
method is its simplicity and economy. The melting or 
fusion method was first proposed by sekiguchi and obi 
to prepare fast release solid dispersion dosage forms. In 
this the physical mixture of a drug and water soluble 
carrier are heated directly until the two melts. The 
melted mixture cooled and solidified rapidly and the 
final solids mass, is then crushed, pulverized and sieved 
which can sieve which can be compressed into tablets 
with the help of tableting agents 
43.
 
2) Solvent evaporation method: 
Tachibana and nakamura were the first to dissolve both 
the drug and the carrier un a common solvent and then 
evaporate the solvent under vacuum to produce a solid 
solution. This enable them to produce ac solid solution 
of the highly lipophilic   - carotene in the highly water 
soluble carrier providone 
44.
 
3) Hot-Melt Extrusion: 
Hot melt extrusion is essentially the same as the fusion 
method except that intense mixing of the components is 
induced by the extruder 
45.
 
4) Nanosuspension 
Nanosuspension technology has been developed as a 
promising candidate for efficient delivery of 
hydrophobic drugs. This technology is applied to poorly 
soluble drug that are insoluble in both water and oils. A 
pharmaceutical nanosuspension is a biphasic system 
consisting of nano sized drug particles stabilized by 
surfactants for either oral and topical use of parenteral 
and pulmonary administration. The particles size of the 
nanosuspension is usually less than one micron with an 
average particle size ranging between 200 and 600nm 
31,46. 
5) Super Critical Fluid (SCF) process: 
Supercritical fluid process is another novel solubilisation 
process. In which supercritical fluids whose temperature 
and pressure are greater than its critical temperature (Tc) 
and critical pressure (Tp), allowing it to assure the 
properties of both a liquid and gas. At near- critical 
temperature SCF, are highly compressible allowing 
moderate changes in pressure to greatly alter the density 
and mass.
38
 Once the drug particles are solubilized 
within the SCF (usually carbon dioxide). They may 
recrystallize at greatly reduced particle sizes. The SCF 
process allows micronisation of drug particle within 
narrow range of particle size, often to submicron level 
47.
 
6) Inclusion complex formation-based technique: 
Among all the solubility enhancement technique, 
inclusion complex formation technique has been 
employed more precisely to improve the aqueous 
solubility, dissolution rate, and bioavailability of poorly 
water soluble drugs. Inclusion complex are formed by 
the insertion of the nonpolar molecules or the nonpolar 
region of one molecule (known as guest) into the cavity 
of another molecule or group of molecules (known as 
host) 
48.
 Various technological adapted to prepare the 
inclusion complexes of poorly water soluble drugs are. 
 Kneading method 
 Lyophilization / freeze drying technique 
 Microwave Irradiation method. 
 
7) Hydrotrophy: 
Hydrotrophy is a solubilisation process, whereby 
addition of a large amount of second solute, the 
hydrotropic agent result in an increase in the aqueous 
solubility of first solute. Hydrotropic agent are ionic 
organic salts, consist of alkali metal salt of various 
organic acids 
49.
 
Partition Coefficient 
A measurement of drugs lipophilicity and an indication 
of its ability to cross cell membranes is the oil/water 
partition coefficient in system such as octanol/water and 
chloroform/water. The partition coefficient is defined as 
the ratio of un-ionized drug distributed between the 
aqueous phase at equilibrium organic and. 
  
 
 
  
     
      
             
A sample of the drug is shaken with a mixture of octanol 
and water and its concentration in each layer IS 
determined 
39. 
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Fig.10: solubility of hydrocortisone and hydrocortisome 21-heptanoate in propylene glycol-water mixtures. (From 
Lachman Leon, Lieberman Herbert A. and Kanig Joseph L. “The theory and pharmaceutical of industrial pharmacy” 
third edition, page no. 188) 
2 
METHODS 
1) A double beam shimadzu -1800 UV-visible 
spectrophotometer, with spectral bandwidth of 
2nm. Wavelength accuracy   0.5 nm and a pair of 1-
cm match quartz cells was used to measure 
absorbance of the resulting solution. Chemical 
which are used in the analysis are. N-octanol, 
salicylic acid and distilled water 
16.
 
2) Abraham solvation parameter model 20. 
The Abraham general solvation model is one of the 
more useful approaches for the analysis and 
predication of the adsorption, distribution and 
toxicological properties of potential drug candidates. 
The method relies on two linear free energy 
relationship one for transfer processes occurring with 
condensed phase. 
                                          
And  one  for  process  involving  gas  to  condensed   
phase  transfer. 
SP = C + e. E + s .S + a .A + b .B + l .L. 
Where , E and S refer to the excess molar refraction 
and bipolarity/polarization descriptor of the solute and 
A and B are measure of solute hydrogen bond activity 
and basicity , V is the McGowan volume and the V 
and L ,are both the measurement of solute size and also 
determine the solute-solvent interaction. 
 
DISSOLUTION 
Dissolution of a drug particle is controlled by several 
physicochemical properties, including chemical form, 
crystal habit, particle size, solubility surface area, and 
wetting properties. The dissolution rate of drug 
substance in which surface area is constant during 
dissolution is described by the modified Noyes-
Whiting equation. 
  
  
 
  
  
        
Where, D is the diffusion coefficient, h is the thickness 
of the diffusion layer at the solid liquid interface. , A is 
the surface area of drug exposed to dissolution media, 
v is the volume of media, Cs is the concentration of a 
saturated solution of the solute in the dissolution 
medium at the experimental temp. And C is the drug in 
solution at time t 
2. 
Dissolution experiments with drug suspension are 
further complicated by changing surface, area 
changing surface crystal morphology and interstitial 
wetting. However, dissolution profiles with excess 
drug can be used to characterize metastable 
polymorphs or solvates. 
Several factors that must be considered in design of 
dissolution test. 
 Factor relating to dissolution apparatus. 
 Factor relating to dissolution fluid 
 Process parameter. 
Table 3: Types of apparatus used in dissolution 
USP Apparatus Name 
Apparatus 1 Rotating basket 
Apparatus 2 Rotating paddle 
Apparatus 3 Reciprocating cylinder 
Apparatus 4 Flow through cell 
Apparatus 5 Paddle overdisc 
Apparatus 6 Cylinder 
Apparatus 7 Reciprocating disc 
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Figure 11: Two basket attachment designs: On the left is the O-ring design and on the right is the three-pronged USP 
Apparatus 1 design. 
 
STABILITY ANALYSIS 
Preformulation stability studies are usually the first 
quantitative assessment of chemical stability of a new 
drug. These studies include both solution and solid state 
experiments under condition typical for the handling 
formulation, storage, and administration of a drug 
candidate. The section focuses on the evaluation of 
chemical stability during preformulation research. 
During drug development several bulk lots are produces, 
reflecting scale- up and process improvements in yield, 
purity and possible crystability 
50
. Upon completion of 
the initial stability tests one or more challenge model 
indicating stability may emerge that may be useful for 
limited testing on future bulk lots or formulation. Should 
a particularly difficult instability problem arise during 
drug development then an in-depth elucidation of the 
decay mechanism may suggest a stabilization approach 
or underscore the futility of the stabilization effort. 
51
 
1) Stability in toxicology formulation: 
Since toxicology studies typically commence early in 
drug development, it is often advisable to evaluate 
sample of the toxicology preparations for stability and 
potential homogeneity problems. Usually a drug feed or 
by oral gavage of an aqueous vehicle 
52
. Water, vitamins 
, minerals (metal ions) enzyme and a multitude of 
functional group are present in feed, which can severely 
reduce the shelf- life of a drug enzyme activity and 
moisture level typically decrease with time while feed 
composition varies with in consumer 
2.
 
Since enzyme activity and mobility of absorbed water 
vary substantially with temperature it is recommended 
that storage temperature typically of the toxicology 
laboratory be used for this stability study. Solution and 
suspension toxicological preparation should be checked 
for ease of man ufacture and the various temperatures in 
addition to chemical stability the suspension should be 
subjected to an occasional shaking to check 
dispersability. When analyzing the suspension data. 
Drug solubility at the same temp, and pH may suggest 
that only drug in solution is undergoing decomposition 
53.
 
2)  Solution Stability 
The primary objective of this phase of preformulation 
research is identification of condition necessary to form 
a stable solution. 
 pH 
 temperature 
 light 
 oxygen 
 co-solvent 
 ionic strength 
- Aqueous Solution for inj. PH 3 containing ironotecan 
HCl, phosphate buffer and WFI was stably prepared by 
dissolving camptothecins without resorting to heating in 
the course of production. 
- Solution stability investigation usually commences 
with probing experiments to confirm decay at the 
extremes of PH and temp 
54.
 
- Since most solution pharmaceuticals are intended for 
parenteral routes of administration. This initial pH rate 
study should that is compatible with physiological 
media. 
- Co-solvent may be needed to achieve drug 
concentration that is necessary for analytic sensitivity or 
to produce a defined initial condition 
55.
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- Chitosan hydrogel can change reversibly well at diff. 
pH and ionic strength of solution. 
- If the result of this result solution stability studies 
dictate the compounds as sufficiently stable liquid 
formulation can be developed 
56.
 
- Once the stability solution is prepared aliquots are 
placed in flint glass ampoules, flame sealed to prevent 
evaporation. Some of these solution samples should be 
subjected to a light stability test, which includes 
protective packaging in amber and yellow green glass 
containers. 
- Given that the potential for oxidation is initially 
unknown some of the solution samples should be 
subjected to further testing. 
1) With an excessive headspace of oxygen. 
2) With a headspace of an invert gas such as helium or 
nitrogen. 
3) With an inorganic antioxidant such as sodium 
metabisulfite. 
4) With an organic antioxidant such as butylated 
hydroxytoulene – BHT. 57 
 
3) SOLID STATE STABILITY 
The primary objectives of this investigation are 
identification of stable storage condition for drug in the 
solid state and identification of compatible excipients for 
a formulation. Contrary to the earlier solution stability 
profile, these solid state studies may be severely affected 
by changes in purity and crystallinity
58.
 In general, solid 
state reacts are much slower and more difficult to 
interpret than solution states react. Owing to reduced no. 
of molecular contacts between drug and excipients 
molecules and to the occurrence of multiple reacts 
59.
 
Solids state stability studies by- 
1) Polymorphic change detected by IR spectroscopy and 
DSC. 
2) Surface discoloration by diffuse reflecting equipment 
to determine the solid state stability profile of a new 
compound weight sample are placed in open screw 
cap vials and are exposed directly to a variety of 
emp. Humidity and light intensity up to 12 week. 
After that samples analyzed by HPLC. 
Table 4: sample scheme for determining the bulk 
stability profile. 
2
 
                                                 Storage condition 
Refrigerator                 –                                5oC 
Room temperature       -                                 25
o
C 
Cold                             -                                 2-8
o
C 
Cool                             –                                8-25oC 
Warm                           –                                30-40oC 
Excessive Heat             –                               above 40oC 
Freezer                          -                               -20 to -10
o
C 
                  
 
Techniques for solid states stabilty studies  
- Solid state NMR spectroscopy (SSNMR). 
- Power X-rays diffraction (PXRD). 
- Fourier transforms IR (FTIR).  
- Raman spectroscopy  
- Differential scanning Calorimetry (DSC). 
- Thermo gravimetric analysis (TGA). 
- Dynamic vapor sorption (DSV) 2 
 
CONCLUSION 
Preformulation studies have a significant part to play in 
anticipating formulation problems and identifying 
logical path in both liquid and solid dosage from 
technology. The need for adequate drug solubility 
cannot be emphasized. The most appropriate salt for 
development, Stabilities studies in solution will indicate 
the feasibility of parenteral or other liquid dosage form 
and can identify methods of stabilization. In parallel 
solid-state stability by DSC, TLC and HPLC in the 
presence of tablet and capsule excipient will indicate the 
most acceptable vehicles for solid dosage form. 
By comparing the physicochemical properties of each 
drug candidate with in a therapeutic group, the 
preformulation scientist can assist the synthetic chemist 
to identify the optimum molecule, provide the biologist 
with suitable vehicles to elicit pharmacological response 
and advise the bulk chemist about the appropriate 
particle size and morphology for subsequent processing.
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